| Target | FLT1 |
|---|
| Product Type | Antibody |
|---|
| Application | ICC, IF, WB |
|---|
| Clonality | Polyclonal |
|---|
| Conjugate | unconjugated |
|---|
| Isotype | IgG |
|---|
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 1100-1180 of human VEGFR1 (NP_002010.2). |
|---|
| Host Species | Rabbit |
|---|
| Species Reactivity | Human, Mouse, Rat |
|---|
| Formulation | PBS with 0.01% thimerosal,50% glycerol |
|---|
| Research Area | Cancer, Immunology, Metabolism |
|---|
| Description/Background | <p>This gene encodes a member of the vascular endothelial growth factor receptor (VEGFR) family. VEGFR family members are receptor tyrosine kinases (RTKs) which contain an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and a tyrosine kinase (TK) domain within the cytoplasmic domain. This protein binds to VEGFR-A, VEGFR-B and placental growth factor and plays an important role in angiogenesis and vasculogenesis. Expression of this receptor is found in vascular endothelial cells, placental trophoblast cells and peripheral blood monocytes. Multiple transcript variants encoding different isoforms have been found for this gene. Isoforms include a full-length transmembrane receptor isoform and shortened, soluble isoforms. The soluble isoforms are associated with the onset of pre-eclampsia.</p> |
|---|
| Protocols | ICC, IF, WB |
|---|
| Molecular Weight | 151kDa |
|---|
| Purity | Affinity purification |
|---|
| Regulatory Statement | For Research Use Only. Not for use in diagnostic procedures. |
|---|
